Related Experiment Video
Updated: May 21, 2026

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
Published on: April 19, 2017
Azole preexposure affects the Aspergillus fumigatus population in patients
Alexandre Alanio1, Odile Cabaret, Emilie Sitterlé
1Institut Pasteur, Unité de mycologie moléculaire, Paris, France.
Abstract:
The relationship between the azole preexposure of 86 patients and the genotype, azole susceptibility, and cyp51A polymorphisms of 110 corresponding Aspergillus fumigatus isolates was explored. Isolates carrying serial polymorphisms (F46Y and M172V with or without N248T with or without D255E with or without E427K) had higher itraconazole MICs (P = 0.04), although <2 μg/ml using the EUCAST methodology, were associated with two genetic clusters (P < 0.001) and with voriconazole preexposure of patients (P = 0.016). Voriconazole preexposure influences the distribution of A. fumigatus isolates with selection of isolates carrying cyp51A polymorphisms and higher itraconazole MICs.
Insights
Voriconazole preexposure in patients selects for Aspergillus fumigatus isolates with specific CYP51A gene mutations. These mutations are linked to higher itraconazole minimum inhibitory concentrations (MICs).
Area of Science:
- Medical Mycology
- Antifungal Resistance
- Clinical Microbiology
Background:
- Azole antifungals are crucial for treating Aspergillus fumigatus infections.
- Emergence of azole resistance in A. fumigatus is a significant clinical concern.
- CYP51A gene polymorphisms are a known mechanism of azole resistance.
Purpose of the Study:
- To investigate the impact of patient azole preexposure on A. fumigatus isolate characteristics.
- To correlate CYP51A polymorphisms with azole susceptibility and genetic clustering.
- To understand the selection pressures exerted by voriconazole preexposure.
Main Methods:
- Analysis of 110 A. fumigatus isolates from 86 patients with known azole preexposure history.
- Genotyping of isolates to identify CYP51A polymorphisms.
- Determination of azole susceptibility using EUCAST methodology, including itraconazole and voriconazole.
- Phylogenetic analysis to identify genetic clusters.
Main Results:
- Isolates with specific CYP51A polymorphisms (F46Y, M172V, N248T, D255E, E427K) exhibited higher itraconazole MICs (P = 0.04).
- These polymorphic isolates were associated with two distinct genetic clusters (P < 0.001).
- Voriconazole preexposure was significantly linked to the selection of these A. fumigatus isolates (P = 0.016).
Conclusions:
- Patient voriconazole preexposure drives the selection of A. fumigatus isolates harboring CYP51A polymorphisms.
- These selected isolates demonstrate reduced susceptibility to itraconazole.
- Understanding these selection dynamics is vital for optimizing antifungal treatment strategies.
Related Concept Videos
Fungal Phylum Ascomycota
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Antifungal Agents
Fungal Phylum Microsporidia
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...

